| Generics - APIs | Development, manufacturing, and sale of active pharmaceutical ingredients for generic drugs | Strong backward integration, regulatory approvals (USFDA, WHO), and proprietary molecules | B2B customers including global pharma firms and drug formulators | Highly specialized oncology and ARV APIs | 1974 | 35 | Sales to multinational pharmaceutical companies and generic drug manufacturers | Contractual sales with volume-based pricing, tenders for donor-funded markets | Demand in ARVs, oncology generics, and market expansion in emerging economies | ARV APIs including Tenofovir, Oncological APIs, Hepatitis C drugs |
| Generics - Finished Dosage Forms (FDF) | Oral solid formulations manufacturing and sale | In-house manufacturing scale, partnerships with global health organizations | B2B and B2C in emerging markets and global generic players | Branded generics and tender-driven markets | 1536 | 27 | Product sales to generic drug companies and direct sales in emerging markets | Unit-based sales and supply agreements with generics | Capacity expansion, rising demand in ARV and oncology treatment | ARV formulations e.g., TLD, Hepatitis C combos |
| Synthesis (CDMO) | CDMO services for global pharmaceutical innovators, including flow chemistry and bio-catalysis | Proprietary technology platforms, regulatory certifications, and deep customer relationships | Global pharma innovators (B2B) requiring development and commercial manufacturing | High-tech biocatalysis and peptide synthesis services | 1491 | 27 | Contract manufacturing fees and milestone payments from pharma partners | Fee-for-service, long-term contracts, milestone-based revenues | Growth in outsourcing, demand for complex synthesis and biologics | Contract development and manufacturing projects in small molecules and biotech |
| Ingredients (Nutraceutical & Cosmeceutical) | Manufacture and sale of specialty ingredients for nutraceutical and cosmetic industries | Integrated supply chain and product innovation capabilities | B2B focus on nutraceutical and personal care industries | Proprietary specialty chemicals | 88 | 1 | Sales to ingredient formulators and consumer product manufacturers | Direct sales with contract manufacturing options | Rising demand for natural and specialty ingredients | Specialty nutritional and cosmetic ingredients |
